• 11/11/2024

Novo Nordisk Expands Cardio Push with German Buy

Wall Street Journal

Novo Nordisk is buying Cardior Pharmaceuticals for around $1 billion as the Wegovy maker moves to strengthen its pipeline of drugs to treat cardiovascular disease and expand into areas outside of its core diabetes and weight-loss market.

https://www.wsj.com/articles/novo-nordisk-boosts-cardiovascular-pipeline-with-eur1-bln-cardior-pharmaceuticals-buy-b7d7da8b